| Table 1.FDA-Approved Treatment Options for H. pylori |
Omeprazole 40 mg QD + Clarithromycin 500 mg TID x 2 weeks, then Omeprazole 20 mg QD x 2 weeks
Bismuth subsalicylate (Pepto Bismol) 525 mg QID + Metronidazole 250 mg QID + Tetracycline 500 mg QID* x 2 weeks + H2 receptor antagonist therapy as directed x 4 weeks
Ranitidine bismuth citrate (RBC) 400 mg BID = Clarithromycin 500 mg TID x 2 weeks than RBC 400 mg BID x 2 weeks
Bismuth subsalicylate (Pepto Bismal) 525 mg QID + Metronidazole 250 mg QID + Tetracycline 500 mg QID* x 2 weeks + H2 receptor antagonist therapy as directed x 4 weeks
Lansoprazole 30 mg BID + Amoxicillin 1 g BID + Clarithromycin 500 mg BID x 14 days
Lansoprazole 30 mg TID + Amoxicillin 1 g TID x 14 days**
|
*Although not FDA approved, amoxicillin has been substituted for tetracycline for patients in whom tetracycline is not recommended.
**This dual therapy regimen has restrictive labeling, it is indicated for patients who are either allergic or intolerant to clarithromycin or for infections with known or suspected resistance to clarithromycin.
|
